Engineering a multilayered thin-film agarose-based hydrogel to support adipose-derived stromal vascular fraction therapy in spinal cord injury.
Veneruso V., Giorgi Z., Petillo E., Frigerio E., Pizzetti F., Roato I.
Animal Study on Spinal Cord Injury, Chronic Inflammation, published in Int J Biol Macromol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Int J Biol Macromol (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42190778
- DOI
- 10.1016/j.ijbiomac.2026.152683
Abstract (original English)
Acute spinal cord injury (SCI) remains a devastating neurological condition with limited therapeutic options. While cell therapy using adipose-derived stromal vascular fraction (SVF) represents a promising approach, effective delivery strategies are critical for clinical success. To address this challenge, this study introduces an innovative therapeutic platform based on a multi-layered thin-film hydrogel, specifically engineered to optimize SVF cell delivery and functionality. By overcoming the critical limitations of traditional bulk hydrogels-such as restricted nutrient diffusion and heterogeneous cell distribution-this layered architecture ensures a uniform cellular microenvironment throughout the three-dimensional space. To further enhance biological performance, an extracellular matrix (ECM) pre-deposition strategy was implemented. By pre-coating the hydrogel layers with SVF-derived ECM, a highly supportive niche was established that significantly promotes cell adhesion and prolonged viability compared to naïve scaffolds. In vivo assessments using intravital microscopy in an SCI model demonstrated the superior efficacy of this system. Specifically, the layered hydrogel successfully preserved SVF viability for extended periods, marking a significant improvement over direct intraparenchymal injections, which resulted in rapid cell degeneration. Furthermore, the hydrogel con
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol - Level ASystematic ReviewPubMed
Brain-derived neurotrophic factor (BDNF) as biomarker in stem cell-based therapies of preclinical spinal cord injury models: A systematic review.
Systematic Review on Spinal Cord Injury, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Cell3 citations - Level ASystematic ReviewEurope PMC
Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects
Systematic Review on Spinal Cord Injury, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
- 2025
Bioact Mater5 citations - Level ASystematic ReviewEurope PMC
Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends
Systematic Review with a reported sample of 42 on Diabetic Foot, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 42
Adv Sci (Weinh)18 citations - Level ASystematic ReviewEurope PMC
Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in Front Neurosci (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurosci